SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Co. Ltd. Announce Positive CHMP Opinion for Conditional Approval of ADCETRIS® (brentuximab vedotin) in Europe